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Hemorrhage is one of the most striking effects of bites by viper snakes resulting in fast bleeding and
ischemia in affected tissues. Snake venom metalloproteinases (SVMPs) are responsible for hemorrhagic
activity, but the mechanisms involved in SVMP-induced hemorrhage are not entirely understood and the
study of such mechanisms greatly depends on in vivo experiments. In vivo, hemorrhagic SVMPs accu-
mulate on basement membrane (BM) of venules and capillary vessels allowing the hydrolysis of collagen
IV with consequent weakness and rupture of capillary walls. These effects are not reproducible in vitro
with conventional endothelial cell cultures. In this study we used two-dimension (2D) or three-
dimension (3D) cultures of HUVECs on matrigel and observed the same characteristics as in ex vivo
experiments: only the hemorrhagic toxin was able to localize on surfaces or internalize endothelial cells
in 2D cultures or in the surface of tubules formed on 3D cultures. The contribution of matrigel, ﬁbro-
nectin and collagen matrices in jararhagin-induced endothelial cell damage was then analyzed. Collagen
and matrigel substrates enhanced the endothelial cell damage induced by jararhagin allowing toxin
binding to focal adhesions, disruption of stress ﬁbers, detachment and apoptosis. The higher afﬁnity of
jararhagin to collagen than to ﬁbronectin explains the localization of the toxin within BM. Moreover,
once located in BM, interactions of jararhagin with a2b1 integrin would favor its localization on focal
adhesions, as observed in our study. The accumulation of toxin in focal adhesions, observed only in cells
grown in collagen matrices, would explain the enhancement of cell damage in these matrices and reﬂects
the actual interaction among toxin, endothelial cells and BM components that occurs in vivo and results
in the hemorrhagic lesions induced by viper venoms.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
Extracellular matrix (ECM) consists of a complex macromolec-
ular network responsible for tissue structural integrity and modu-
lation of cellular activity. Collagens are the most abundant proteins
in the ECM. Collagen remodeling by matrix metalloproteinases
(MMPs) is commonly observed during normal tissue homeostasis.
A rapid and extensive degradation of collagens is also detected in
some pathological situations, such as cancer, autoimmune diseases
(Rosenblum et al., 2010), and on pathogenesis of venom-inducedMoura-da-Silva).hemorrhage that involves direct damage of microvessels (Baldo
et al., 2010).
Venom induced hemorrhage is a relevant symptom of enven-
omationwith viper snakes and causes the massive local damage by
disruption of capillary vessels. Consequently, blood leaks into tis-
sues and distal tissues become ischemic due to the lack of blood
supply. Venom-induced hemorrhage has been attributed to the
ability of snake venom metalloproteinases (SVMPs) to degrade
basement membrane (BM) components (Baramova et al., 1989;
Escalante et al., 2006). However, different SVMPs are described
and they vary considerably in hemorrhagic activity. PIII-class
SVMPs are generally potent hemorrhagins while PI-class SVMPs
present weak or undetectable hemorrhagic activity. Since both PI
and PIII-SVMPs are equally able to degrade ECM components, the
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tivity is the presence of additional adhesive domains, present only
in PIII SVMPs, which could potentiate the catalytic action of the
toxins by binding to ECM or endothelial cells (Fox and Serrano,
2005; Kamiguti et al., 1996; Tanjoni et al., 2010). This issue was
investigated by our group comparing the mechanisms related to
hemorrhagic activity of jararhagin, a well-known hemorrhagic PIII
SVMP isolated from Bothrops jararaca venom (Paine et al., 1992) and
BnP1, a non-hemorrhagic PI SVMP isolated from Bothrops neuwiedi
venom (Baldo et al., 2008). The results demonstrated that hemor-
rhagic activity of jararhagin is correlated to its ability to bind to
collagen (Baldo et al., 2010; Moura-da-Silva et al., 2008). In vivo, this
toxin is able to selectively degrade the ﬁbrillar collagen and base-
ment membrane collagen IV, co-localizing with the basement
membrane of capillaries and venules on mouse skin (Baldo et al.,
2010). On the other hand, BnP1 hydrolyzed ECM components
in vitro (Baldo et al., 2008), but in vivo the toxin did not accumulate
nearby blood vessels nor hydrolyzed BM collagens. These evidences
have been recently conﬁrmed by Herrera et al., 2015 observing
tissue localization of two hemorrhagic SVMPs, CsH1 (PIII-SVMP
from Crotalus simus) and BlatH1 (PII-SVMP from Bothriechis later-
alis), but not of BaP1, a weakly-hemorrhagic PI-SVMP from Bothrops
asper. In this sense, these observations strongly suggest the relevant
role of interactions between adhesive domains present in the
toxins and BM components enhancing the proteolytic effect of
these enzymes, allowing disruption of microvessel walls.
Endothelial cells are also essential for the integrity of micro-
vessels and the role of endothelial cells damage on hemorrhagic
activity by PIII-SVMPs is another still open question. In vitro, both
hemorrhagic and non-hemorrhagic SVMPs induce apoptosis of
endothelial cells at comparable levels (Diaz et al., 2005; Tanjoni
et al., 2005). Additionally, hemorrhage induced by jararhagin
in vivo occurs much faster than the apoptosis of endothelial cells
in vitro, and apoptotic cells were not detected on hemorrhagic le-
sions induced by SVMP from B. asper venom (Jimenez et al., 2008),
ruling out that apoptosis of these cells is the prevalent mechanism
for hemorrhages observed in vivo. However, apparently discrepant
results obtained in vivo and in vitro may be due to the absence of
experimental conditions that accurately model a complex micro-
environment observed in vivo. Most of these studies were per-
formed using endothelial cells grown on conventional culture
bottles, which are static and rigid surfaces. Therefore, they are very
distinct from the matrix microenvironment observed in vivo. In
agreement with that, differences concerning proliferation, migra-
tion, morphology and activation of signaling pathways were
observed when cells are grown in substrates such as ﬁbronectin
and collagen, compared to cells grown in absence of ECM compo-
nent (Berrier and Yamada, 2007; Lim et al., 2010; Soucy and Romer,
2009). Moreover, the discrepancy noted on action of SVMPs in vitro
and in vivo could be due to inappropriate methods used to evaluate
the action of SVMPs in vitro.
In this sense, the aim of this studywas to investigate the effect of
jararhagin on endothelial cells cultured on different matrices, using
primary culture of HUVECs as model. This set of experiments re-
veals that cells grown in collagen matrices are more susceptible to
the action of jararhagin which concentrates in focal adhesion, dis-
rupts cellematrix interaction and enhances cell susceptibility to
apoptosis. The results showed here can bring new insights about
the mechanisms of SVMP-induced pathology.
2. Material and Methods
2.1. Toxins
Jararhagin was isolated from B. jararaca snake venom aspreviously described (Paine et al., 1992) with modiﬁcations
(Moura-da-Silva et al., 2003). BnP1 was puriﬁed from B. neuwiedi
venom according to Baldo et al. (2008). The purity of toxins was
evaluated by SDS-PAGE 12.5%, under reducing conditions. Toxins
were used in the native form or labeled with Alexa Fluor 488®
(Molecular Probes, USA) according to the manufacturer in-
structions. BSA (Bovine serum albumin e Sigma Aldrich, USA) was
used as control of non-toxic protein in different sets of
experiments.
2.2. Cell culture
HUVECs were harvested by type IV collagenase (Worthington,
USA) digestion as described by Jaffe et al. (1973) and cultured on
gelatin-coated plastic dishes in RPMI 1640 medium supplemented
with 10% FBS, 2mM L-glutamine,1mM sodium pyruvate,100 UI/mL
penicillin, 100 mg/mL streptomycin, 50 uM 2-mercaptoethanol, 5 U/
mL heparin and 20 ng/mL bFGF. For bidimensional cultures (2D), 96
or 24 wells microplates were coated with type I collagen (BD
Bioscience, USA), type IV collagen (BD Bioscience, USA), ﬁbronectin
(Invitrogen, USA) or matrigel (Sigma Aldrich, USA) in a ﬁnal con-
centration of 50 mg/mL. Cells cultured on gelatin 1% or uncoated
plates were used as a control. For three-dimensional cultures (3D),
30 mL of matrigel were added to a 24 well microplates containing
glass coverslips (13 mm), following incubation of 30 min, 37 C.
After that, 0.5  105 cells were added on the top of gelled matrigel
and cultured in the HUVECs medium for approximately 18 h, 37 C.
After that, the capillary-like structures could be observed.
2.3. Immunoﬂuorescence assays
Immunoﬂuorescence experiments were carried out using
markers for actin cytoskeleton (rhodamine-phalloidin), focal ad-
hesions (vinculin), and basement membrane (collagen IV and
laminin) as described below. In order to investigate the interaction
of toxins with HUVECs, cells were treated with 800 nM Alexa Fluor
488-labeled jararhagin (Alexa488-Jar), Alexa Fluor 488-labeled
BnP1 (Alexa488-BnP1) or Alexa Fluor 488-labeled BSA (Alexa488-
BSA) for 30 min. The samples were ﬁxed in 3.7% formaldehyde
for 10 min at room temperature. Nonspeciﬁc staining was blocked
by incubating the coverslips for 1 h at room temperature with a
solution of Phosphate Buffer Saline (PBS) containing 1% triton X-
100, 5% normal goat serum, 1% BSA, 0.5% glycine and 0.5% ﬁsh skin
gelatin. For cells cultured on 2D-model, the actin cytoskeleton was
stained with rhodamine phalloidin (1:100-Invitrogen, USA) by in-
cubation for 1 h, at room temperature. In 3-D model, the basement
membrane of HUVEC tube-like structures were labeled by goat
anti-rabbit type IV collagen polyclonal antibody (Chemicon, USA),
or goat anti-rabbit laminin polyclonal antibody (Chemicon, USA),
both at a 1:40 dilution, for 18 h at 4 C. After washing with PBS, the
sections were incubated with anti-rabbit IgG conjugated to Tetra-
methylrhodamine (TRITC) at 1: 500 dilution (Molecular Probes,
USA), for 90 min at room temperature. For the analysis of focal
adhesion and cytoskeleton alterations induced by jararhagin,
HUVECs were treated with 800 nM of toxins or BSA for 3 h. Cells
treated with PBS were used as negative control. The samples were
ﬁxed and blocked as described above and incubated overnight at
4 C with mouse anti-vinculin antibodies (1:100- Sigma Aldrich,
USA) and after washing, cells were incubated with Alexa ﬂuor 488-
labeled goat anti-mouse IgG (1:1000 eMolecular Probes, USA) and
rhodamine phalloidin (1:100) for 1 h, at room temperature. Nega-
tive control consisted of omitting the primary antibody step from
the protocol. The effect of extracellular matrix on morphology and
spreading of HUVECs on 2-D model was evaluated in non-treated
cells. The samples were examined with a Confocal Microscope
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carried out using the LMS Image Browser (Zeiss) software based on
rhodamine phalloidin staining.
2.4. Flow cytometry assays
The direct interaction of jararhagin with HUVECs or a2b1
integrin present on cell membrane was evaluated by ﬂow cytom-
etry, using cells cultured on collagen I, ﬁbronectin or matrigel
during 2 days. After that, the cells were harvested by trypsin and
the concentration adjusted to 106 cells/30 mL PBS containing 1%
BSA. Cells were incubated with anti-FcgRII/III monoclonal antibody
(1 mg/106 cells - BD Biosciences, USA), for 15 min, at 4 C, washed
with PBS containing 1% BSA, and resuspended in culture medium.
Cultures were incubated with 800 nM Alexa488-Jar for 30 min. Cell
suspensions were also incubated with FITC-labeled IgG-isotype
control mAb (R&D System, USA) or Alexa488-BSA. For a2b1 integrin,
cells cultured on collagen I were incubated with 800 nM of non-
labeled jararhagin for 30 min at 37 C. After washing, cells were
incubated with anti-a2 integrin (CD49b- R&D Systems, USA), in the
concentration of 1 mg/106 of cells in PBS/1% BSA, for 30 min/4 C.
The cells were centrifuged and resuspended in 0.2 mL of PBS with
1% paraformaldehyde. Flow cytometry of triplicate samples (104
events/data acquisition ﬁle) were performed with FACSCalibur
(Becton Dickinson, USA) using CellQuest Software (BD Biosciences,
USA). The results were expressed as the percentage of positively
labeled cells.
2.5. Solid phase assays
To evaluate the interaction between jararhagin and ECM com-
ponents, collagen I (10 mg/mL in 0.1 M of acetic acid), ﬁbronectin
(10 mg/mL in PBS), or matrigel (10 mg/mL in PBS) were coated on
microtiter plate wells and incubated overnight at 4 C. After
blocking with 1% of BSA in TBS, pH 7.4, different dilutions of jar-
arhaginwere added to the plates and incubated for 2 h, at 37 C. For
a2b1 integrin binding assays, the collagen-binding site of a2b1
integrin, the a2A domain, was obtained as described (Calderwood
et al., 1997; Eble and Tuckwell, 2003). The recombinant fragment
was coated on microtiter plate (5 mg/mL in PBS) and TBS buffer
containing 2 mM MgCl2 was used for washing procedures. Bound
jararhagin was detected with rabbit polyclonal antiserum against
jararhagin, followed by alkaline phosphatase-coupled secondary
antibody and the enzyme substrate. Binding intensity was accessed
by optical density at 492 nm.
2.6. Apoptosis assays
Apoptosis was accessed by the DNA content of cells stained with
Hypotonic Fluorescent Solution (50 mg/mL propidium iodide, 0.1%
Triton X-100 and 0.1% sodium citrate), analyzed by FACScalibur
(BectoneDickinson, USA). DNA fragmentation was quantiﬁed by
cell cycle analysis of total DNA content as previously described
(Nicoletti et al., 1991). Using the FSC x SSC parameters, debris were
gated out and 10,000 events were counted. Acquisition and analysis
were performed with CellQuest software (BectoneDickinson, USA)
and the results represent the percentage of the population gated in
the region corresponded to sub-G1 phase (fractional DNA content).
Samples were run in triplicates of two independents experiments.
3. Ethical statements
Human vascular endothelial cells (HUVECS) were obtained from
umbilical cords of newborns (Hospital of University of S~ao Paulo:
Ethical Committee for Human Protocol: 526/04).4. Results and discussion
4.1. Interaction of jararhagin and BnP1 with endothelial cells
According to our previous data, jararhagin exhibits high afﬁnity
to collagen and this binding is essential for the expression of
hemorrhagic activity in vivo (Baldo et al., 2010; Moura-da-Silva
et al., 2008). Thus, our ﬁrst step in this study was to evaluate if
2D or 3D cultures with ECM components would reproduce the
same mechanism in vitro. For this purpose, we included in our
experiments also BnP1, a non-hemorrhagic PI-class SVMP, which in
previous experiments (Baldo et al., 2008) did not show any inter-
action with collagens in solid phase assays. Jararhagin and BnP1
interaction with HUVECs were then evaluated in cells cultured on
matrigel in 2D- and 3D-models. As shown in Fig. 1A, in the 2D-
model, binding of jararhagin to HUVECs was detectable after
30 min of treatment as it localized preferentially at cell surface
regions where actin ﬁbers were also abundant. In contrast, treat-
mentwith BnP1 did not result in any detectable ﬂuorescence signal,
similarly to control cells incubated with Alexa488-BSA, indicating
that non-hemorrhagic PeI SVMPs do not bind to endothelial cells
cultured on matrigel. Similar results were found on 3D cultures:
after 30min treatment with jararhagin or BnP1, only jararhaginwas
concentrated near the tube-like structures formed by endothelial
cells and was localized close to capillary-like structures up to 6 h of
incubation whilst no signal was detected in BnP1 or BSA treated
cultures (Fig. 1B). Binding of jararhagin to the basement membrane
of capillary-like structures was then investigated by a double-
staining protocol using Alexa488-Jar and collagen IV or laminin.
Treatment of cells with labeled jararhagin revealed ﬂuorescent
staining around capillary vessels, which co-localized with base-
ment membrane staining of collagen IV or laminin labeled anti-
bodies (Fig. 2), in line with our previous in vivo experiments (Baldo
et al., 2010).
The mechanical properties and molecular composition of the
extracellular matrix determine the patterns of adhesion, migration
and morphology, deeply inﬂuencing the behavior of cells (Discher
et al., 2005). Also, the susceptibility of cells to deleterious treat-
ments may be affected by the microenvironment in which cells are
cultured. In this aspect, we could reproduce our previous ex vivo
evidences in vitro, as jararhagin interacted with BM components
likewise in the 3Dmatrigel system and in microvessels (Baldo et al.,
2010; Herrera et al., 2015; Moura-da-Silva et al., 2008). Binding of
PIII-class SVMPs to BM components in the in vivo model, and their
localization in microvessel walls were correlated with enhanced
hydrolysis of collagen IV (Baldo et al., 2010; Herrera et al., 2015)
resulting in hemorrhage because of weakness and rupture of the
vessel (Gutierrez et al., 2005). Interestingly, we did not detect any
binding of Alexa488-Jar to collagen presented in matrigel, either in
2D or 3D cultures (Fig. 1). Two different hypotheses could explain
this observation: either the arrangement of collagen included in
matrigel is different than the one observed in solid phase assay
coated plates, resulting in different exposition of the epitopes
responsible for jararhagin binding or the interaction between jar-
arhagin and endothelial BM components depends also on interac-
tion with endothelial cell surface markers. Therefore, our next step
was to investigate the cellular target of jararhagin on different ECM
components and in endothelial cell surface markers.
In solid phase assays, high afﬁnity binding of jararhagin to
collagen was conﬁrmed using isolated collagen or matrigel, which
contains collagen IV. In opposition, no binding was observed be-
tween jararhagin and ﬁbronectin (Fig. 3A). This is in agreement
with previous data showing that collagens are preferred targets of
PIII-class SVMPs amongst the ECM molecules. Binding of PIII-class
SVMPs was demonstrated in vitro to ECM proteins as collagen I
Fig. 1. Interaction of Alexa488-labeled SVMPs with HUVECs cultured on matrigel on 2D (A) and 3D (B) systems. HUVECs were treated with 800 nM of Alexa488-Jar or Alexa488-
BnP1 for 30 min. Cells treated with Alexa488-BSAwere used as control. Actin ﬁlaments were stained with rhodamin phalloidin (1:100). The samples were examined with a Confocal
Microscope LSM 510 Meta (Zeiss).
Fig. 2. Binding of jararhagin to the capillary-like 3D structures. HUVECs cultured on 3D system were treated with 800 nM of Alexa488-Jar for 30 min and incubated with goat anti-
rabbit type IV collagen polyclonal antibody or goat anti-rabbit laminin polyclonal antibody (1:40), followed by incubation with anti-rabbit IgG conjugated to TRITC (1:500). The
samples were analyzed in confocal microscope (LSM-510-Meta, Zeiss).
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collagen IV (Moura-da-Silva et al., 2008), collagen XII and XIV and
the matrilins 1, 3 and 4 (Serrano et al., 2006). To test the interaction
between jararhagin and endothelial cell surface markers, we used
the a2b1 integrin as target based on previous results showing that
jararhagin presents afﬁnity for this receptor (De-Luca et al., 1995;
Moura-da-Silva et al., 2001; Tanjoni et al., 2010). In solid phase
assays, jararhaginwas able to bind to immobilized recombinant a2A
domain integrin subunit (Fig. 3B). The a2A domain is the recognized
collagen-binding site within a2b1 integrin (Calderwood et al., 1997;
Emsley et al., 1997). In addition, several regions of jararhagin
molecule may act as ligands for a2A domain present in a2b1 integrin
as a cyclic RKKH peptide derived from a charged hydrophilic region
of metalloproteinase domain of jararhagin (Ivaska et al., 1999;
Pentik€ainen et al., 1999) or the A domain present on vWF as the
hypervariable region present on the cysteine-rich domain of class
P-III SVMPs (Serrano et al., 2006). Additionally, the binding of anti-
a2 antibodies to endothelial cells was reduced approximately 50%
when cultures were treated with jararhagin. This indicates the a2b1
integrin-directed antibodies compete with jararhagin for the samereceptor (Fig. 3C). Therefore, a2b1 integrin may be involved in
jararhagin-endothelial cells interaction. Thus, our data, presented
here, support the previous evidences that both disintegrin-like
(Kamiguti et al., 1997; Moura-da-Silva et al., 2008; Tanjoni et al.,
2010) and cysteine rich domains (Serrano et al., 2006, 2005, 2007)
are involved in the binding to ECM proteins and integrin receptors
indicating that non-enzymatic mechanisms are also involved in the
action of hemorrhagic SVMPs.
According to these data, the localization of jararhagin to the
endothelial cell- BM-zone is possibly driven by interaction with
ECM components as well as endothelial cell surface markers. These
evidences prompted us to investigate the effect of jararhagin in
endothelial cells cultured in collagen containing matrices or in
ﬁbronectin substrate, which expressed strong and no interaction
with the toxin, respectively.
4.2. Inﬂuence of ECM proteins on HUVECs behavior
In order to evaluate the effect of jararhagin on endothelial cells
cultured on different substrates, we ﬁrst evaluated the behavior of
Fig. 3. Binding of jararhagin to ECM components and endothelial cells. (A) Binding of jararhagin to ECM substrates and (B) to the a2A domain of a2b1 integrin by solid phase assay:
Different toxin concentrations were incubated with collagen I, ﬁbronectin, matrigel or to the a2A domain previously immobilized to a microtiter plate. Bound jararhagin was
quantiﬁed by ELISA by polyclonal anti-jararhagin antibodies, as described in Material and Methods. The results are expressed as the mean of the optical density obtained in the
samples run in triplicate ± SD of one from three representative experiments. The symbol (*) represents a signiﬁcant difference (p < 0.05) compared with samples non-treated with
jararhagin (Control). (C) Binding of jararhagin to HUVECs surface: Cells were incubated or not with 800 nM jararhagin for 30 min. After this, the cells were incubated with FITC-
conjugated anti-a2 subunit of a2b1 integrin (CD49b) antibody followed by ﬂow cytometry analysis. The results represent the mean of the percentage of a2b1 positive cells of the
samples run in triplicate ± SD. Samples of cells incubated with FITC-conjugated IgG isotype control antibody were used as control. The symbol (*) represents a signiﬁcant difference
(p < 0.05) compared with the control group.
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differences in cell shape, size and actin distribution could be
observed. On collagen IV, ﬁbronectin andmatrigel, endothelial cells
showed an increased spreading area and a polygonal morphology
with a larger number of stress ﬁbers. On contrary, cells grown in the
absence of substrate i.e. only in plastic bottles or in the presence of
gelatin showed an elongated morphology with actin ﬁbers
distributed in the peripheral region of the cell, and a reduction of
spreading area. Cells cultured in collagen I presented an interme-
diate behavior with a slight increase in cell spreading, elongated
morphology and most of actin ﬁbers in the periphery (Fig. 4A). The
quantiﬁcation of the spreading area, showed statistically signiﬁcant
differences in the spreading area of cells cultured in collagen I and
IV, ﬁbronectin andmatrigel (Fig. 4B). These results showed that size
and cell shape of HUVECs are profoundly inﬂuenced by ECM
constitution and are in agreement with the literature that already
showed that the constitution of the ECM substrates is able to affect
the morphology, differentiation and proliferation of cells (Discher
et al., 2005; Engler et al., 2004). Considering the differences in
endothelial cells behavior in collagen I, ﬁbronectin and matrigel
matrices and the differences of jararhagin interaction to these ECM
proteins in vitro, these substrates were chosen to the next set of
experiments.
4.3. Interaction of jararhagin and endothelial cells cultured on
different matrices
Binding of jararhagin to HUVECs cultured on ﬁbronectin,
collagen and matrigel substrates was next analyzed. As shown in
Fig. 5, labeled jararhagin was detected in endothelial cells grown in
the three different substrates (Fig. 5A). On contrary, cells treatedwith Alexa488-BSA did not shown any labeling, showing the
speciﬁcity of the test. In cells cultured on ﬁbronectin, the ﬂuores-
cence signal was concentrated inside the cell, close to the nucleus,
indicating that jararhagin may be internalized in HUVECs cultured
on these conditions (Fig. 5A-Fibronectin). In contrast, in collagen
matrices (collagen-I and matrigel), jararhagin was mostly detected
on the cell surface and co-localized with the extremity of actin
stress ﬁbers, apparently in focal adhesion regions (Fig. 5A). The
shape of jararhagin treated cells grown in different matrices was
also different with clear signs of retraction of actin ﬁbers and
detachment on cells cultured on matrigel or collagen substrates,
while the cells cultured on ﬁbronectin presented a similar shape of
control cells despite the treatment with jararhagin (Fig. 5A). Ac-
cording to these observations, it is reasonable to suggest that the
interaction of the toxin with matrix components drives jararhagin
fate within the cell. High afﬁnity binding of jararhagin to collagen
approximates the toxin to integrins present in the focal adhesions
and concentrates the catalytic action of the enzyme towards pro-
teins essential to cell anchorage, leading to detachment. In contrast,
in ﬁbronectin matrix, jararhagin binds only to integrin receptor and
without an extra support due to the lack of binding to ECM, the
toxin possibly takes a preferential route for cell internalization.
Speciﬁc binding of jararhagin to HUVECs was also detected by ﬂow
cytometry in cells treated for 30 min with jararhagin on different
substrates. In these experiments, the ﬂuorescent signal due to jar-
arhagin binding was equally detected on cells cultured on collagen,
matrigel and ﬁbronectin (Fig. 5B), since the method detects
ﬂorescent signals from cell surface or internalized jararhagin.
Cell shape is controlled by the cytoskeleton that acts as a me-
chanically supporting framework (Ingber, 1993; Wang et al., 1993).
Alterations of the actin cytoskeleton may be a signal for apoptosis
Fig. 4. Effect of extracellular matrix on morphology and spreading of HUVECs on 2D model. Cells were cultured on 24-well plates previously coated with different ECM substrates
for 18 h. Cells grown on gelatin and uncoated plates were also evaluated. A) Actin ﬁlaments were stained with rhodamin phalloidin (1:100) and cultures were examined with a
Confocal Microscope LSM 510 Meta (Zeiss). B) Spreading cell area based on F-actin staining. Quantiﬁcation of actin stained was carried out using the LMS Image Browser (Zeiss)
software. The experiment was performed in quadruplicate and the data are expressed as mean ± s.d. of one representative experiment. Signiﬁcance was calculated by Student's T
and the symbol (*) represents a signiﬁcant difference (p < 0.05) compared to uncoated.
Fig. 5. Interaction of Alexa488-labeled SVMPs with HUVECs cultured on matrigel, ﬁbronectin and collagen I on 2D-model. HUVECs were treated with 800 nM of Alexa488-Jar for
30 min. Cells treated with Alexa488-BSA were used as control. A) Cultures were observed by immunoﬂuorescence with actin ﬁlaments stained with rhodamin phalloidin (1:100).
The samples were examined with a Confocal Microscope LSM 510 Meta (Zeiss). B) Interaction of Alexa488-Jar with HUVECs was quantiﬁed by ﬂow cytometry analysis of triplicate
samples with FACSCalibur (Becton Dickinson, USA) using CellQuest Software (BD Biosciences). The results express the percentage of cells expressing Alexa488-Jar. The experiment
was carried out in triplicate and the signiﬁcance was calculated by Student's T test. The symbol * represent signiﬁcant difference (p < 0.05) compared to samples treated with the
control (Alexa488-BSA).
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et al. (2001) showed the ability of cytoskeleton to control the
endothelial cell survival through Bcl-2 expression as well as via
phosphorylation of protein kinase Akt. Thus, the interference on
endothelial cell cytoskeletal structure caused by jararhagin may
correlate with the initiation of apoptosis signal transduction. Thus,we next investigated the alterations induced by jararhagin on
cytoskeleton and focal adhesions. Fig. 6 shows the control cells with
the typical distribution of actin ﬁbers with vinculin spots on cells
borders. After 3 h of jararhagin treatment, a diffuse distribution of
vinculin throughout the cytoplasm was observed in cells grown on
all tested substrates. On collagen I and matrigel, cells retracted,
C. Baldo et al. / Toxicon 108 (2015) 240e248246rounded up, and lacked any pattern characteristic of focal adhe-
sions were observed. On ﬁbronectin, the cells showed a minor
retraction of actin cytoskeleton and preserved focal adhesions.
Comparable results were obtained by Lim et al. (2010) studying the
effects of extracellular matrix in smooth muscle cells. The authors
reported a higher coefﬁcient of adhesion and stability of focal ad-
hesions in cells grown in ﬁbronectin than on collagen I and IV. On
ﬁbronectin, the cells were well anchored and less susceptible to
drastic changes. In another study, HUVECs showed different
adherence patterns when grown on matrix derived from ﬁbro-
blasts, where the co-localization of focal adhesions proteins (vin-
culin, pY397FAK, pY410-130Cas) with ﬁbronectin was signiﬁcantly
higher comparedwith collagen I and IV (Soucy and Romer, 2009). In
our experiments, HUVECs cultured on ﬁbronectin were more
resistant to the treatment with jararhagin and preserved the focal
adhesion structures as observed by the immunoﬂuorescence for
vinculin. However, in our model, jararhagin did not co-localize with
actin ﬁbers or focal adhesion in ﬁbronectin cultures but showed an
apparent internalization to the endothelial cell. A remarkable dif-
ferencewas observed in HUVECs cultured in collagenmatrices with
a co-localization of the toxin with actin ﬁbers and focal adhesions
(Fig. 5). The higher concentration of jararhagin with these struc-
tures in initial times would enhance the disruption cell anchorage
signaling to apoptosis.
Apoptosis was then accessed by DNA fragmentation by ﬂow
cytometry. As shown in Fig. 7, incubation of endothelial cells with
jararhagin resulted in DNA fragmentation preferentially on cells
plated on matrigel and collagen. At 100 nM jararhagin, hypodiploid
nucleic cells were 43.26% and 31.12% in cultures grown in matrigel
and collagen I, respectively. At higher concentrations (800 nM)
jararhagin induced DNA fragmentation in a higher number of cells
(matrigele79.10%; collagen Ie72.20%). DNA fragmentationwas also
observed on cells plated on ﬁbronectin, but to a minor extent, at
both concentrations of jararhagin (100 nMe11.32%;
800 nMe56.28%).
In previous studies, apoptosis of HUVECs cultured on gelatinwasFig. 6. Focal adhesion and cytoskeleton alteration induced by jararhagin in HUVECs cultur
jararhagin for 3 h. Cells treated with PBS were used as a control. Focal adhesions were staine
488 goat anti-mouse IgG (1:1000). The cytoskeletonwas stained with rhodamine phalloidin
spots on control cells borders. The samples were examined with a Confocal Microscope LSinduced only 48 h after treatment with 800 nM jararhagin (Baldo
et al., 2008) and the same length of time and toxin concentration
were needed to induce apoptosis in tEnd cells cultured in plastic
surface (Tanjoni et al., 2005). The signaling pathways observed in
the latter study included a reduced phosphorylation of FAK as well
as its association to cytoskeleton proteins, an increase in Bax levels
and the processing of pro-caspase-3. This suggested that disruption
of focal adhesion was the main mechanism involved in jararhagin-
induced apoptosis (Tanjoni et al., 2005). The same mechanisms
may be applied to jararhagin induced apoptosis in HUVECs cultured
on collagen matrices since retraction of cytoskeleton and disrup-
tion of focal adhesions were associated with the treatment with the
toxin. However, the strength of the apoptotic signal was much
higher in cells cultured in collagen matrices and the reaction
occurred much faster with reduced concentrations of the toxin,
showing the relevant role of the extracellular matrix components
on the behavior of endothelial cells treated with jararhagin.5. Concluding remarks
In this study we showed that 2D- or 3D-cultures of HUVECs on
matrigel are good models to exploit in vitro the intrinsic mecha-
nisms related to disruption of capillary vessels and to venom-
induced hemorrhage. As previously observed in ex vivo experi-
ments, only the hemorrhagic toxin was able to localize to endo-
thelial cells in 2D-cultures or to the surface of tubules formed on
3D-cultures. In this scenario, collagen reproduced the effects
observed in matrigel cultures enhancing the endothelial cell dam-
age induced by jararhagin that includes binding to focal adhesions,
disruption of stress ﬁbers, detachment and apoptosis. Considering
that the macromolecular organization and the biomechanical sta-
bility of BM is mainly determined by the network of type IV
collagen (Kühn, 1995), the afﬁnity of jararhagin to collagen would
drive the localization of the toxin within BM. Moreover, once
located in BM, interactions of jararhagin with a2b1 integrin would
favor its localization on focal adhesions, as observed in our study.ed in different components of extracellular matrix. Cells were treated with 800 nM of
d with mouse anti-vinculin antibodies (1:100) followed by incubation with Alexa ﬂuor
(1:100). The small square highlights the typical distribution of actin ﬁbers with vinculin
M 510 Meta (Zeiss).
Fig. 7. Induction of apoptosis by jararhagin in HUVECs cultured in different components of extracellular matrix. Cells were treated with 100 or 800 nM jararhagin for 6 h. Cells
treated with PBS were used as a control. Apoptosis was evaluated by ﬂow cytometry analysis of DNA content. Data are expressed as mean ± SD of one representative experiment
performed in triplicate. * p < 0.05, vs. correspondent control (T test).
C. Baldo et al. / Toxicon 108 (2015) 240e248 247The accumulation of toxin in focal adhesions, observed only in cells
grown in collagen matrices, would explain the enhancement of cell
damage in these matrices and reﬂects the actual interaction among
toxin, endothelial cells and BM components that occurs in vivo and
results in the hemorrhagic lesions induced by viper venoms.
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